X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1301) 1301
Publication (156) 156
Book Chapter (20) 20
Book Review (8) 8
Conference Proceeding (5) 5
Dissertation (4) 4
Paper (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dlbcl (920) 920
humans (701) 701
index medicus (671) 671
oncology (485) 485
male (433) 433
female (418) 418
lymphomas (389) 389
middle aged (389) 389
aged (362) 362
hematology (355) 355
prognosis (308) 308
lymphoma, large b-cell, diffuse - pathology (295) 295
adult (283) 283
chemotherapy (281) 281
lymphoma, large b-cell, diffuse - drug therapy (262) 262
rituximab (259) 259
diffuse large b-cell lymphoma (244) 244
cancer (243) 243
lymphoma (242) 242
non-hodgkins-lymphoma (214) 214
survival (214) 214
lymphoma, large b-cell, diffuse - genetics (213) 213
hemic and lymphatic diseases (211) 211
aged, 80 and over (210) 210
expression (192) 192
b-cell lymphoma (185) 185
antineoplastic combined chemotherapy protocols - therapeutic use (178) 178
lymphoma, large b-cell, diffuse - mortality (156) 156
immunohistochemistry (154) 154
treatment outcome (151) 151
lymphoma, large b-cell, diffuse - metabolism (148) 148
immune system diseases (143) 143
pathology (141) 141
r-chop (141) 141
elderly-patients (128) 128
analysis (126) 126
retrospective studies (123) 123
young adult (122) 122
lymphoma, large b-cell, diffuse - diagnosis (115) 115
adolescent (113) 113
medicine & public health (108) 108
lymphocytes b (102) 102
disease-free survival (101) 101
gene expression (99) 99
cell biology (96) 96
care and treatment (94) 94
therapy (87) 87
apoptosis (84) 84
cell line, tumor (84) 84
vincristine - administration & dosage (84) 84
cyclophosphamide - administration & dosage (83) 83
chop (80) 80
doxorubicin - administration & dosage (80) 80
neoplasm staging (80) 80
classification (79) 79
prednisone - administration & dosage (78) 78
article (77) 77
genetic aspects (75) 75
lymphoma, large b-cell, diffuse - therapy (75) 75
antineoplastic combined chemotherapy protocols - administration & dosage (74) 74
gene expression regulation, neoplastic (74) 74
vincristine - therapeutic use (74) 74
animals (72) 72
doxorubicin - therapeutic use (72) 72
kaplan-meier estimate (72) 72
cyclophosphamide - therapeutic use (71) 71
prednisone - therapeutic use (70) 70
research (69) 69
survival analysis (69) 69
gene-expression (68) 68
follicular lymphoma (67) 67
activation (64) 64
myc (64) 64
bcl2 (63) 63
non-hodgkin's lymphomas (63) 63
diffuse large b cell lymphoma (61) 61
mutation (61) 61
health aspects (60) 60
immunology (60) 60
non-hodgkin-lymphoma (60) 60
gene expression profiling (58) 58
risk factors (58) 58
antibodies, monoclonal, murine-derived - administration & dosage (57) 57
gene (57) 57
diagnosis (56) 56
leukemia (56) 56
patients (56) 56
tumors (54) 54
lymphoma, large b-cell, diffuse - immunology (53) 53
trial (53) 53
chemotherapy plus rituximab (51) 51
medical prognosis (51) 51
non-hodgkin lymphoma (51) 51
antineoplastic agents - therapeutic use (50) 50
chronic lymphocytic-leukemia (50) 50
cyclophosphamide (50) 50
doxorubicin (50) 50
nf-kappa-b (50) 50
survival rate (50) 50
proteins (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1277) 1277
Japanese (19) 19
Polish (9) 9
German (5) 5
Hungarian (5) 5
Russian (5) 5
Chinese (4) 4
Korean (3) 3
Spanish (2) 2
French (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


TERAPEVTICHESKII ARKHIV, ISSN 0040-3660, 2018, Volume 90, Issue 7, pp. 96 - 101
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC) subtype, also referred to as... 
SURVIVAL | DLBCL | INTENSIFIED CHEMOTHERAPY | R-CHOP | KAPPA-B | GCB-DLBCL | auto-hematopoietic stem cell transplantation | non-GCB-DLBCL | RANDOMIZED PHASE-3 TRIAL | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | RITUXIMAB | INITIAL THERAPY | NON-HODGKINS-LYMPHOMA | AAN-DLBCL | lenalidomide | ELDERLY-PATIENTS | GCB- DLBCL | non-GCB- DLBCL | АВС- DLBCL
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 05/2013, Volume 13, Issue 5, pp. 1305 - 1316
Journal Article
Oncotarget, ISSN 1949-2553, 08/2018, Volume 9, Issue 64, pp. 32383 - 32399
Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 30% of non-Hodgkin lymphoma (NHL) cases in adult series. DLBCL is characterized by marked... 
DLBCL entities | DLBCL | Treatment | Risk assessment | Guidelines
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2363 - 2370
Abstract Background Gene expression profiling (GEP) studies recognized a prognostic role for tumor microenvironment (TME) in diffuse large B-cell lymphoma... 
Cell-of-origin | Deconvolution | DLBCL | Digital expression analysis | Microenvironment | Prognosticators | SIGNATURES | R-CHOP | TUMOR | CHEMOTHERAPY | microenvironment | deconvolution | B-CELL LYMPHOMA | ONCOLOGY | digital expression analysis | DEREGULATION | STROMA | cell-of-origin | prognosticators | Original
Journal Article
Annals of Diagnostic Pathology, ISSN 1092-9134, 02/2019, Volume 38, pp. 6 - 10
The recent 2017 update of the World Health Organization classification of lymphomas has significant changes from the previous edition. Subtypes of large B cell... 
Molecular classification of DLBCL | DLBCL | Large B cell lymphoma | Aggressive lymphoma | WHO classification | DLBCL subtypes | SUBTYPE | IDENTIFY | HODGKIN LYMPHOMA | PATHOLOGY | Analysis | Lymphomas
Journal Article
Molecular Cancer, ISSN 1476-4598, 12/2015, Volume 14, Issue 1, pp. 207 - 207
Journal Article